Order Article Reprints

Franceschinis E, Roverso M, Gabbia D, De Martin S, Brusegan M, Vaccarin C, Bogialli S, Chilin A. Self-Emulsifying Formulations to Increase the Oral Bioavailability of 4,6,4′-Trimethylangelicin as a Possible Treatment for Cystic Fibrosis. Pharmaceutics. 2022; 14(9):1806. https://doi.org/10.3390/pharmaceutics14091806

Franceschinis, Erica, Marco Roverso, Daniela Gabbia, Sara De Martin, Matteo Brusegan, Christian Vaccarin, Sara Bogialli, and Adriana Chilin. 2022. "Self-Emulsifying Formulations to Increase the Oral Bioavailability of 4,6,4′-Trimethylangelicin as a Possible Treatment for Cystic Fibrosis" Pharmaceutics 14, no. 9: 1806. https://doi.org/10.3390/pharmaceutics14091806

Franceschinis, E., Roverso, M., Gabbia, D., De Martin, S., Brusegan, M., Vaccarin, C., Bogialli, S., & Chilin, A. (2022). Self-Emulsifying Formulations to Increase the Oral Bioavailability of 4,6,4′-Trimethylangelicin as a Possible Treatment for Cystic Fibrosis. Pharmaceutics, 14(9), 1806. https://doi.org/10.3390/pharmaceutics14091806